176 related articles for article (PubMed ID: 4729321)
1. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
Alberto P
Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321
[No Abstract] [Full Text] [Related]
2. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
Maurer LH; Tulloh M; Eagan RT; Forcier RJ; House R
Cancer Chemother Rep 3; 1973 Mar; 4(2):171-6. PubMed ID: 4354041
[No Abstract] [Full Text] [Related]
4. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in bronchogenic carcinoma.
Ojala A; Nikkanen VN; Palojoki A; Paloheimo S
Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
7. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW
Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
Dundalek E
Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
[No Abstract] [Full Text] [Related]
9. [Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma].
Castberg T; Kruse-Blinkenberg HO
Ugeskr Laeger; 1976 Jun; 138(24):1449-55. PubMed ID: 1273973
[No Abstract] [Full Text] [Related]
10. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
Bitran JD; Desser RK; DeMeester T; Golomb HM
JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy in bronchogenic carcinoma (author's transl)].
Bruntsch U
Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy and radiation therapy in small cell carcinoma of the lung.
Eagan RT; Maurer LH; Forcier RJ; Tulloh M
Cancer; 1973 Aug; 32(2):371-9. PubMed ID: 4722918
[No Abstract] [Full Text] [Related]
13. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
Lad T; Sarma PR; Diekamp U; Tichler T; Chawla M; Krauss S; Zawila P; Nelson R
Cancer Clin Trials; 1979; 2(4):321-6. PubMed ID: 394868
[TBL] [Abstract][Full Text] [Related]
14. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester T; Shapiro CM; Billings A; Rubenstein L; Evans R; Colman M; Rao CY; Griem M; Golomb HM
Cancer Treat Rep; 1978 Mar; 62(3):327-32. PubMed ID: 348305
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
Bonadonna G; Tancini G; Bajetta E
Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
[No Abstract] [Full Text] [Related]
16. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
Livingston RB
Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
[No Abstract] [Full Text] [Related]
17. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
[No Abstract] [Full Text] [Related]
18. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
[No Abstract] [Full Text] [Related]
19. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
Brunner KW; Marthaler T; Müller W
Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
[No Abstract] [Full Text] [Related]
20. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
